NanoViricides (NNVC) Fundamental Analysis: Revenue, Earnings & Valuation

9.00 / 10

Outperform

Fundamental assessment scores 9.0/10, rating Outperform. Key bullish factors include high interest coverage, robust revenue growth, strong inventory turnover, and favorable asset‑to‑market ratios. Weak points are elevated long‑term debt relative to working capital and a full current‑liabilities ratio, but overall fundamentals remain excellent.

Analysis Checks(8/10)

Revenue-MV

Value-0.11

Score3/3

Weight39.82%

1M Return8.11%

Total operating revenue (YoY growth rate %)

Value134.00

Score2/3

Weight0.55%

1M Return0.13%

Inventory turnover ratio

Value103.94

Score2/3

Weight-4.54%

1M Return-1.18%

Current liabilities / Total liabilities (%)

Value100.00

Score0/3

Weight-16.82%

1M Return-4.96%

PB-ROE

Value0.38

Score2/3

Weight37.14%

1M Return7.29%

Long-term debt to working capital ratio (%)

Value6.39

Score0/3

Weight-17.30%

1M Return-4.75%

Interest coverage ratio (EBIT / Interest expense) (%)

Value35.11

Score2/3

Weight-4.62%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value177.16

Score2/3

Weight0.22%

1M Return0.05%

Cost of sales ratio (%)

Value64.41

Score2/3

Weight-4.36%

1M Return-1.13%

Asset-MV

Value-0.55

Score3/3

Weight69.91%

1M Return11.61%

Is NNVC fundamentally strong?

NNVC scores 9.00/10 on fundamentals and holds a Discounted valuation at present. Backed by its -43.10% ROE, 0.00% net margin, -2.42 P/E ratio, 1.81 P/B ratio, and 30.99% earnings growth, these metrics solidify its Outperform investment rating.